PMDL Pace Medical Inc (GM)

Pace Medical, Inc. (Pink Sheets: PMDL) announced today that a new, enhanced version of the AccuPace�, Pacing Analyzer, has met early sales expectations. Demand for the device, which analyzes the permanent heart wires (leads) installed for implantable heart pacemakers and defibrillators, has been strong. Increased production is forecasted and plans to ramp up production in January are being scheduled. Pace Medical is the only U.S. company that designs and manufactures a standalone Pacing Analyzer, a device that is needed in every operation for a permanent pacemaker or defibrillator. The new version has an enhanced LCD display, new User-Friendly connector terminals, improved operator preset parameters and utilizes a state-of-the-art surface mounted electronic assembly method. The new AccuPace is the first step in an enhanced product line of Pacing Analyzers and Temporary Cardiac Pacemakers, designed and manufactured in the U.S. by Pace Medical. �This Pacing Analyzer is a building block towards a family of products that are needed by the medical community worldwide.� stated Ralph E. Hanson, Chairman. Pace Medical, Inc. designs and manufactures Single and Dual-Chamber Temporary Cardiac Pacemakers, Dual-Chamber Pacing Analyzers, Reusable and Single-Use Surgical and Patient Extension Cables and related Accessories. For additional information contact Steven E. Hanson, President & CEO at 858-350-8821 or pacemedicalpres@aol.com.